APA (7th ed.) Citation

Anderson, K. G., Oda, S. K., Bates, B. M., Burnett, M. G., Suarez, M. R., Ruskin, S. L., & Greenberg, P. D. (2021, July 31). Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy bioRxiv. https://doi.org/10.1101/2021.07.30.454539

Chicago Style (17th ed.) Citation

Anderson, Kristin G., Shannon K. Oda, Breanna M. Bates, Madison G. Burnett, Magdalia Rodgers Suarez, Susan L. Ruskin, and Philip D. Greenberg. "Engineering Adoptive T Cell Therapy to Co-opt Fas Ligand-mediated Death Signaling in Ovarian Cancer Enhances Therapeutic Efficacy." BioRxiv 31 Jul. 2021. https://doi.org/10.1101/2021.07.30.454539.

MLA (9th ed.) Citation

Anderson, Kristin G., et al. "Engineering Adoptive T Cell Therapy to Co-opt Fas Ligand-mediated Death Signaling in Ovarian Cancer Enhances Therapeutic Efficacy." BioRxiv, 31 Jul. 2021, https://doi.org/10.1101/2021.07.30.454539.